Skip to main content
Veterinary Medicines

Marfloxin 80 mg Tablets for Dogs

Authorised
  • Marbofloxacin

Product identification

Medicine name:
Marfloxin 80 mg Tablets for Dogs
Marfloxin 80 mg compresse per cani
Active substance:
  • Marbofloxacin
Target species:
  • Dog
Route of administration:
  • Oral use

Product details

Active substance and strength:
  • Marbofloxacin
    80.00
    milligram(s)
    /
    1.00
    Tablet
Pharmaceutical form:
  • Tablet
Withdrawal period by route of administration:
  • Oral use
    • Dog
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QJ01MA93
Authorisation status:
  • Valid
Authorised in:
  • Italy
Package description:
  • box containing 72 tablets (12 blister)
  • box containing 12 tablets (2 blister)

Additional information

Entitlement type:
  • Marketing Authorisation
Marketing authorisation holder:
  • KRKA tovarna zdravil d.d. Novo mesto
Marketing authorisation date:
Manufacturing sites for batch release:
  • Krka d.d. Novo Mesto
  • Tad Pharma GmbH
  • Krka-Farma d.o.o.
Responsible authority:
  • Ministry Of Health
Authorisation number:
  • 104492
Date of authorisation status change:
Reference member state:
  • Spain
Procedure number:
  • ES/V/0317/003
Concerned member states:
  • Austria
  • Belgium
  • Bulgaria
  • Czechia
  • Denmark
  • Estonia
  • Finland
  • France
  • Germany
  • Greece
  • Hungary
  • Ireland
  • Italy
  • Latvia
  • Lithuania
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Romania
  • Slovakia
  • Slovenia
  • United Kingdom (Northern Ireland)

Documents

Combined File of all Documents

This document does not exist in this language (English). You can find it in another language below.
Italian (PDF)
Published on: 28/03/2022

Summary of Product Characteristics

English (PDF)
Published on: 22/12/2023
Download

eu-PUAR-esv0317003-dcp-marfloxin-80-mg-tablets-for-dogs-en.pdf

English (PDF)
Published on: 21/12/2023
Download
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."